ScholarIQanswers from OpenAlex

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study

PaperCitations, authors & open-access status

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study have?

ScholarIQcitation count

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study has 184 citations in the OpenAlex counts ScholarIQ stores.

When was Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study published?

ScholarIQyear

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study has 2016 year in the ScholarIQ index.

What is the open-access status of Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?

ScholarIQoa status

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study has hybrid oa status in the ScholarIQ index.

What is the DOI of Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?

ScholarIQdoi

The DOI for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is on the source record.

What is the PMID of Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?

ScholarIQpmid

The PMID for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is on the source record.

What is the OpenAlex record for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?

ScholarIQopenalex

The OpenAlex for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial